Tyra Bioscience's total assets for Q4 2024 were $363.56M, a decrease of -4.48% from the previous quarter. TYRA total liabilities were $20.41M for the fiscal quarter, a 11.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.